RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00042863.xml
CC BY-NC-ND 4.0 · Indian J Plast Surg 2011; 44(01): 054
DOI: 10.1055/s-0039-1699480
DOI: 10.1055/s-0039-1699480
Commentary
Is Bleomycin a worthy alternative?
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
31. Dezember 2019 (online)
-
REFERENCES
- 1 Yang Y, Sun M, Ma Q, Cheng X, Ao J, Tian L, et al. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations. J Vasc Surg 2011;53:150-5.
- 2 Karavelioğlu A, Temuçin CM, Tanyel FC, Ciftci AO, Senocak ME, Karnak I. Sclerotherapy with bleomycin does not adversely affect facial nerve function in children with cervicofacial cystic lymphatic malformation. J Pediatr Surg 2010;45:1627-32.
- 3 Atwa K, Abuhasna S, Shihab Z, Hashaykeh N, Hasan R. Acute pulmonary toxicity following intralesional administration of bleomycin for a lymphovenous malformation. Pediatr Pulmonol 2010;45: 192-6.
- 4 Mulliken JB, Fischman SJ, Burrow PE. Vascular Anomalies. Curr Prob Surg 2000;37:517.
- 5 Vargas FS, Wang NS, Lee HM, Gruer SE, Sassoon CS, Light RW. Effectiveness of bleomycin in comparison to tetracycline as pleural sclerosing agent in rabbits. Chest 1993;104:1582-4.